Alexander Y. Tokman
CIK: 0001334483
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NDRA
ENDRA Life Sciences Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Tokman Alexander Y
Tokman Alexander Y (SEC CIK 0001334483) files insider reports with the SEC as Chief Executive Officer of ENDRA Life Sciences Inc. (NDRA).
Signal8 holds 2 ownership filings by Tokman Alexander Y, all Form 4s, filed between Jan 23, 2026 and Mar 4, 2026. Those filings report 2 transactions, from Jan 21, 2026 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Tokman Alexander Y's filings is in ANN ARBOR, MI.
Recent filings by Tokman Alexander Y
Other insiders filing for ENDRA Life Sciences Inc. (NDRA)
- ASP Isotopes Inc., 10% Owner
- Jacroux Richard, Chief Financial Officer
- DIGIANDOMENICO ANTHONY, Director
- Harsh Michael, Director
- Basenese Lou, Director
- UBS Group AG, Officer